5,565
likes
2,734
comments
daily view 0
monthly view 0
Live Analytics
Comments 0
Antibody data and US predictions Analytics Table
Income Estimates for Antibody data and US predictions
Based on this YouTube video's total view count of 201K views and industry-standard rates, the estimated total earning is $141 - $403 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About Antibody data and US predictions
Explore Antibody data and US predictions with 201,548 views, 5,565 likes, and 2,734 comments. Experience the impact of this video content that has captured audience attention.
UK ONS, 19th January https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/antibodydatafortheukjanuary2021 December and October antibody percentages Seroconversion, 14 – 21 days Length of time antibodies remain at detectable levels in the blood is not fully known England One in eight (12%) up from 7% Wales One in 10 (10%) up from 4% Scotland One in 11 (9%) up from 7% Northern Ireland One in 13 (8%) up from 2% United States Cases, 23,653,919 Deaths, 394,495 Hospitalizations, 123,848 Vaccinations, 13,989,000 doses given Completed courses, 1,720,000 (0.53%) https:/covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases https://www.washingtonpost.com/graphics/2020/national/coronavirus-us-cases-deaths/?itid=lk_inline_manual_5 Institute for Health Metrics and Evaluation http://www.healthdata.org/sites/default/files/files/Projects/COVID/2021/briefing_US_20210114.pdf http://www.healthdata.org/covid COVID-19 Results Briefing: United States of America Current situation Effective R, greater than 1 in 27 states Effective R is less than 1 in most of the midwest Estimated, 22% have been infected as of January 11 US population, 328 million Therefore number of infections = 72,160,000 Factor of 3 more Therefore IFR = 0.48% CFR = 1,67% Trends Deaths, 567,000 by May 1 This represents 192,000 additional deaths from January 11 to May 1 Likely peak at the beginning of February Daily deaths will peak at 3,680 on February 1, 2021 Steady decline after the peak Reaching below 500 a day sometime in April Factors, seasonality and the scale-up of vaccination By May 1, some states may be close to herd immunity If more transmissible variants spread in the US in the coming weeks Peak could be delayed by weeks Death toll substantially increased Hospitals in many states will be under severe stress in the next four weeks To reduce deaths, masks, some social distancing mandates, rapid scale-up of vaccination Drivers and prevention Mobility continues to decline, 33% lower than the pre-COVID-19 baseline Visits to restaurants and department stores up substantially from the weeks prior. As of January 11, 76% of people always wore a mask when leaving their home All states had mask use over 50%. US, 52.5% of people say they would accept a vaccine, 24.1% unsure We expect, 141 to 179 million people will be vaccinated by May 1 Projections By May 1, 2021, we project that 37,800 to 51,100 lives will be saved by the vaccine rollout Compared to a no-vaccine scenario If universal mask coverage (95%), 31,000 fewer cumulative deaths on May 1, 2021 Mandates easing scenario, 621,000 cumulative deaths on May 1, 2021 January to May, 42 states will have high or extreme stress on hospital beds January to May, 45 states will have high or extreme stress on ICU capacity Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021 https://www.cdc.gov/mmwr/volumes/70/wr/mm7003e2.htm?s_cid=mm7003e2_w Detected in 10 U.S. states Potential to increase the U.S. pandemic trajectory in the coming months Increased transmissibility of the B.1.1.7 variant Warrants universal and increased compliance with mitigation strategies Higher vaccination coverage might need to be achieved to protect the public Genomic sequence, National SARS-CoV-2 Strain Surveillance, targeted approach to identifying variants of concern in the United States Brazil Oxford Astrazeneca and Sinovac, granted an emergency use authorisation in Brazil by ANVISA today (17/01). Sinovac vaccine, 6 million doses manufactured in China are already available and vaccination has started today Brazil Instituto Butantan manufactures the AZ vaccine Oxford vaccine, vaccination is expected to start soon
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard

